Published in Pharmacol Ther on January 21, 2013
The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors. Br J Pharmacol (2013) 2.29
B-RAF kinase drives developmental axon growth and promotes axon regeneration in the injured mature CNS. J Exp Med (2014) 1.65
Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury. J Neurotrauma (2015) 1.42
The stem cell secretome and its role in brain repair. Biochimie (2013) 1.19
Long non-coding RNA-dependent transcriptional regulation in neuronal development and disease. Front Genet (2014) 1.11
Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease. Front Cell Neurosci (2014) 1.07
Gene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN Deficiency. Mol Ther (2016) 1.06
Brain-derived neurotrophic factor in the airways. Pharmacol Ther (2014) 0.94
The protective role of prosaposin and its receptors in the nervous system. Brain Res (2014) 0.94
Neuronal cell cycle: the neuron itself and its circumstances. Cell Cycle (2015) 0.90
The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease. Aging Dis (2015) 0.90
A review of bioactive release from nerve conduits as a neurotherapeutic strategy for neuronal growth in peripheral nerve injury. Biomed Res Int (2014) 0.89
Combined effect of nerve growth factor and brain‑derived neurotrophic factor on neuronal differentiation of neural stem cells and the potential molecular mechanisms. Mol Med Rep (2014) 0.88
MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway. Br J Pharmacol (2015) 0.88
Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells. Front Cell Neurosci (2015) 0.87
Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives. Br J Pharmacol (2014) 0.87
Back to the future with phenotypic screening. ACS Chem Neurosci (2014) 0.86
Tissue engineering is a promising method for the repair of spinal cord injuries (Review). Exp Ther Med (2013) 0.86
Naringin: a protector of the nigrostriatal dopaminergic projection. Exp Neurobiol (2014) 0.86
Effects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brain. Neural Regen Res (2014) 0.85
Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. Int J Nanomedicine (2015) 0.84
Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases. Int J Mol Sci (2014) 0.84
Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound. J Control Release (2015) 0.84
The nerve growth factor signaling and its potential as therapeutic target for glaucoma. Biomed Res Int (2014) 0.83
Pax6 influences expression patterns of genes involved in neuro- degeneration. Ann Neurosci (2015) 0.83
Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons. EMBO Mol Med (2014) 0.82
Chronic amitriptyline treatment attenuates nigrostriatal degeneration and significantly alters trophic support in a rat model of parkinsonism. Neuropsychopharmacology (2014) 0.81
Panax notoginsenoside Rb1 ameliorates Alzheimer's disease by upregulating brain-derived neurotrophic factor and downregulating Tau protein expression. Exp Ther Med (2013) 0.81
Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors. Br J Pharmacol (2015) 0.80
Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury. Neurotherapeutics (2014) 0.80
Mononuclear cells from the cord blood and granulocytecolony stimulating factor-mobilized peripheral blood: is there a potential for treatment of cerebral palsy? Neural Regen Res (2015) 0.80
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease. Ann Clin Transl Neurol (2016) 0.79
Intrastrain comparison of the chemical composition and antioxidant activity of an edible mushroom, Pleurotus giganteus, and its potent neuritogenic properties. ScientificWorldJournal (2014) 0.79
Asarone from Acori Tatarinowii Rhizoma Potentiates the Nerve Growth Factor-Induced Neuronal Differentiation in Cultured PC12 Cells: A Signaling Mediated by Protein Kinase A. PLoS One (2016) 0.79
Combination therapies: The next logical Step for the treatment of synucleinopathies? Mov Disord (2015) 0.79
Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration. Int J Mol Sci (2016) 0.78
Therapeutic approaches in Parkinson's disease and related disorders. J Neurochem (2016) 0.78
Deficiency of GDNF Receptor GFRα1 in Alzheimer's Neurons Results in Neuronal Death. J Neurosci (2014) 0.78
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis. J Neuroinflammation (2016) 0.77
Exercise as Gene Therapy: BDNF and DNA Damage Repair. Asia Pac J Ophthalmol (Phila) (2016) 0.77
Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system. Exp Neurol (2015) 0.77
BBB-Permeable, Neuroprotective, and Neurotrophic Polysaccharide, Midi-GAGR. PLoS One (2016) 0.77
Neuroregeneration and dementia: new treatment options. J Mol Psychiatry (2013) 0.77
Nafamostat Mesilate Improves Neurological Outcome and Axonal Regeneration after Stroke in Rats. Mol Neurobiol (2016) 0.77
Humoral activity of cord blood-derived stem/progenitor cells: implications for stem cell-based adjuvant therapy of neurodegenerative disorders. PLoS One (2013) 0.77
Plasma epidermal growth factor decreased in the early stage of Parkinson's disease. Aging Dis (2015) 0.77
L-serine treatment may improve neurorestoration of rats after permanent focal cerebral ischemia potentially through improvement of neurorepair. PLoS One (2014) 0.76
Modulation of neurotrophic signaling pathways by polyphenols. Drug Des Devel Ther (2015) 0.76
Neurotrophic Activity of Cultured Cell Line U87 is Up-Regulated by Proline-Rich Polypeptide Complex and Its Constituent Nonapeptide. Cell Mol Neurobiol (2015) 0.76
Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection. Adv Exp Med Biol (2017) 0.76
Astrocyte-like cells differentiated from a novel population of CD45-positive cells in adult human peripheral blood. Cell Biol Int (2014) 0.75
Comparing the Behavioural Effects of Exogenous Growth Hormone and Melatonin in Young and Old Wistar Rats. Oxid Med Cell Longev (2016) 0.75
Identification of Centella asiatica's Effective Ingredients for Inducing the Neuronal Differentiation. Evid Based Complement Alternat Med (2016) 0.75
A double-blind, rct testing beneficial modulation of BDNF in middle-aged, life style-stressed subjects: a clue to brain protection? J Clin Diagn Res (2014) 0.75
Back to the tubule: microtubule dynamics in Parkinson's disease. Cell Mol Life Sci (2016) 0.75
Uridine from Pleurotus giganteus and Its Neurite Outgrowth Stimulatory Effects with Underlying Mechanism. PLoS One (2015) 0.75
Neuroprotective Effect of the Marine-Derived Compound 11-Dehydrosinulariolide through DJ-1-Related Pathway in In Vitro and In Vivo Models of Parkinson's Disease. Mar Drugs (2016) 0.75
Pro-Cognitive Properties of the Immunomodulatory Polypeptide Complex, Yolkin, from Chicken Egg Yolk and Colostrum-Derived Substances: Analyses Based on Animal Model of Age-Related Cognitive Deficits. Arch Immunol Ther Exp (Warsz) (2016) 0.75
Bioactivity-guided fractionation identifies amygdalin as a potent neurotrophic agent from herbal medicine Semen Persicae extract. Biomed Res Int (2014) 0.75
Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice. Age (Dordr) (2016) 0.75
Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model. Theranostics (2017) 0.75
Dendrobium alkaloids prevent Aβ25-35-induced neuronal and synaptic loss via promoting neurotrophic factors expression in mice. PeerJ (2016) 0.75
Low-Intensity Extracorporeal Shock Wave Therapy Enhances Brain-Derived Neurotrophic Factor Expression through PERK/ATF4 Signaling Pathway. Int J Mol Sci (2017) 0.75
Cistanche tubulosa Protects Dopaminergic Neurons through Regulation of Apoptosis and Glial Cell-Derived Neurotrophic Factor: in vivo and in vitro. Front Aging Neurosci (2016) 0.75
The Role of Current Techniques and Concepts in Peripheral Nerve Repair. Plast Surg Int (2016) 0.75
Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery. J Neuroimmune Pharmacol (2017) 0.75
Transport of glial cell line-derived neurotrophic factor into liposomes across the blood-brain barrier: in vitro and in vivo studies. Int J Mol Sci (2014) 0.75
Roles of Rheb(S16H) in substantia nigra pars compacta dopaminergic neurons in vivo. Biomed Rep (2014) 0.75
BAC-based cellular model for screening regulators of BDNF gene transcription. BMC Neurosci (2014) 0.75
Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery. J Med Chem (2014) 0.75
Are Temporal Differences in GDNF and NOS Isoform Induction Contributors to Neurodegeneration? A Fluorescence Microscopy-Based Study. Open Neurol J (2016) 0.75
Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis. Exp Neurol (2015) 0.75
Releasing Nrf2 to promote neurite outgrowth. Neural Regen Res (2015) 0.75
In vitro differentiation of neural stem cells into noradrenergic-like cells. Int J Mol Cell Med (2015) 0.75
Naringin as a beneficial natural product against degeneration of the nigrostriatal dopaminergic projection in the adult brain. Neural Regen Res (2017) 0.75
FK962 induces neurite outgrowth in cultured monkey trigeminal ganglion cells. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Topiramate via NMDA, AMPA/kainate, GABAA and Alpha2 receptors and by modulation of CREB/BDNF and Akt/GSK3 signaling pathway exerts neuroprotective effects against methylphenidate-induced neurotoxicity in rats. J Neural Transm (Vienna) (2017) 0.75
Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease. CNS Drugs (2017) 0.75
Post 6-OHDA lesion exposure to stress affects neurotrophic factor expression and aggravates motor impairment. Metab Brain Dis (2017) 0.75
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med (2003) 4.51
Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain (2006) 2.07
Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med (2005) 1.49
Trigeminal neuralgia and its management. BMJ (2007) 1.24
Prevalence and treatment of cephalic arch stenosis in dysfunctional autogenous hemodialysis fistulas. J Vasc Interv Radiol (2003) 1.10
Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin. J Neurochem (2008) 1.05
Stimulation of the subthalamic region for essential tremor. J Neurosurg (2004) 1.05
The neurotrophins and their role in Alzheimer's disease. Curr Neuropharmacol (2011) 0.98
Neuralgia of the glossopharyngeal and vagal nerves: long-term outcome following surgical treatment and literature review. Br J Neurosurg (2010) 0.98
Conformational polymorphism in sulfonylurea drugs: electronic structure analysis. J Phys Chem B (2010) 0.97
Analgesia in conjunction with normalisation of thermal sensation following deep brain stimulation for central post-stroke pain. Pain (2009) 0.91
A magnetic resonance imaging-directed method for transventricular targeting of midline structures for deep brain stimulation using implantable guide tubes. Neurosurgery (2010) 0.85
Foreign accent following brain injury: syndrome or epiphenomenon? Eur Neurol (2005) 0.85
Structure of bacterial glutathione-S-transferase maleyl pyruvate isomerase and implications for mechanism of isomerisation. J Mol Biol (2008) 0.84
Clinicopathological review of patients with and without multiple sclerosis treated by partial sensory rhizotomy for medically refractory trigeminal neuralgia: a 12-year retrospective study. Clin Neurol Neurosurg (2011) 0.79
Spinal arachnoiditis and cyst formation with subarachnoid haemorrhage. Br J Neurosurg (2012) 0.79
Characterising the Analgesic Effect of Different Targets for Deep Brain Stimulation in Trigeminal Anaesthesia Dolorosa. Stereotact Funct Neurosurg (2016) 0.77
Deep brain stimulation for the treatment of resistant hypertension. Curr Hypertens Rep (2014) 0.77
Trochlear myokymia secondary to cerebellopontine angle arachnoid cyst. Br J Neurosurg (2012) 0.76
Implantation of deep brain stimulation electrodes in unshaved patients. J Neurosurg (2003) 0.75
Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery. J Med Chem (2014) 0.75
Novel use of narrow paddle electrodes for occipital nerve stimulation--technical note. Neuromodulation (2012) 0.75
793 Trigeminal Neuralgia in Patients with Multiple Sclerosis: Strategy for Surgical Treatment. Neurosurgery (2000) 0.75
Identification of novel small molecule TGF-β antagonists using structure-based drug design. J Comput Aided Mol Des (2013) 0.75
846 A Prospective Study to Assess the Use of MRA in the Diagnosis of Neurovascular Compression in Patients with Trigeminal Neuralgia and Hemifacial Spasm: Comparison with Surgical Findings. Neurosurgery (2000) 0.75